CMHX008, a PPARγ partial agonist, enhances insulin sensitivity with minor influences on bone loss

Traditional thiazolidinediones (TZDs), such as rosiglitazone, are peroxisome proliferator-activated receptor γ (PPARγ) potent agonists that can be used to treat type 2 diabetes but carry unwanted effects, including increased risk for fracture. The present work aimed to compare the insulin-sensitizin...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Genes and Diseases
المؤلفون الرئيسيون:	Yi Hou, Xuemei Cao, Xiangnan Hu, Xinyu Li, Xiaoqin Shi, Hongying Wang, Chuan Peng, Jiayu Li, Jibin Li, Qifu Li, Chaodong Wu, Xiaoqiu Xiao
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	KeAi Communications Co., Ltd. 2018-09-01
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2352304218300655